Speech and Voice Outcomes Following HD-tDCS Over the Left SMA

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorLouisiana State University and A&M College

About this trial

Pharmaceutical and neurosurgical treatments reliably ameliorate the cardinal motor symptoms in PD but, they often yield inconsistent outcomes for speech and voice disorders, with some studies showing exacerbation of pre-treatment deficits. Therefore, it is crucial to develop and optimize novel approaches that could simultaneously improve speech and voice deficits in PD and facilitate existing behavioral interventions. This project will investigate the immediate and short-term effects of multiple sessions of HD-tDCS over the left SMA on speech and voice deficits in PD.

Eligibility criteria

Qualifiers

Clinical diagnosis of Parkinson's disease

Native English speakers

Adequate age-relative hearing and vision to perform the outlined tasks

Able to provide their own written consent

Disqualifiers

Neurological disorders besides Parkinson's disease

Previous brain surgery including deep brain stimulation

Clinical diagnosis of dementia

Trial design

Treatments tested in this trial

  • Active transcranial direct current stimulation
  • Sham transcranial direct current stimulation

Treatment groups

48 Participants
are divided into 2 treatment groups

Locations

This trial has no locations